The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 341:1420-1425 November 4, 1999 Number 19
NextNext

An Outbreak of Multidrug-Resistant, Quinolone-Resistant Salmonella enterica Serotype Typhimurium DT104
Kåre Mølbak, M.D., Dorte Lau Baggesen, D.V.M., Ph.D., Frank Møller Aarestrup, D.V.M., Ph.D., Jens Munk Ebbesen, D.V.M., Jørgen Engberg, M.D., Kai Frydendahl, D.V.M., Peter Gerner-Smidt, M.D., D.Med.Sci., Andreas Munk Petersen, M.D., and Henrik C. Wegener, Ph.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Food-borne salmonella infections have become a major problem in industrialized countries. The strain of Salmonella enterica serotype typhimurium known as definitive phage type 104 (DT104) is usually resistant to five drugs: ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline. An increasing proportion of DT104 isolates also have reduced susceptibility to fluoroquinolones.

Methods The Danish salmonella surveillance program determines the phage types of all typhimurium strains from the food chain, and in the case of suspected outbreaks, five-drug–resistant strains are characterized by molecular methods. All patients infected with five-drug–resistant typhimurium are interviewed to obtain clinical and epidemiologic data. In 1998, an outbreak of salmonella occurred, in which the strain of typhimurium DT104 was new to Denmark. We investigated this outbreak and report our findings here.

Results Until 1997, DT104 infections made up less than 1 percent of all human salmonella infections. The strain isolated from patients in the first community outbreak of DT104 in Denmark, in 1998, was resistant to nalidixic acid and had reduced susceptibility to fluoroquinolones. The outbreak included 25 culture-confirmed cases. Eleven patients were hospitalized, and two died. The molecular epidemiology and data from patients indicated that the primary source was a Danish swine herd. Furthermore, the investigation suggested reduced clinical effectiveness of treatment with fluoroquinolones.

Conclusions Our investigation of an outbreak of DT104 documented the spread of quinolone-resistant bacteria from food animals to humans; this spread was associated with infections that were difficult to treat. Because of the increase in quinolone resistance in salmonella, the use of fluoroquinolones in food animals should be restricted.


Source Information

From Statens Serum Institut (K.M., J.E., P.G.-S., A.M.P.), the Danish Veterinary Laboratory (D.L.B., F.M.A., K.F.), the Danish Food and Veterinary Administration (J.M.E.), and the Danish Zoonosis Center (H.C.W.) — all in Copenhagen, Denmark.

Address reprint requests to Dr. Mølbak at Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark.

Full Text of this Article


Related Letters:

Respiratory Distress Associated with Zanamivir
Williamson J. C., Pegram P. S.
Extract | Full Text  
N Engl J Med 2000; 342:661-662, Mar 2, 2000. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.